Insider Transactions in Q2 2025 at Healthequity, Inc. (HQY)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 09
2025
|
Robert W Selander |
SELL
Open market or private sale
|
Direct |
5,750
-2.15%
|
$442,750
$77.89 P/Share
|
Apr 09
2025
|
Robert W Selander |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+12.11%
|
$350,000
$28.68 P/Share
|
Apr 08
2025
|
Stephen Neeleman FOUNDER AND VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct |
9,019
-7.35%
|
$712,501
$79.88 P/Share
|
Apr 08
2025
|
Delano Ladd EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,991
-7.48%
|
$552,289
$79.88 P/Share
|
Apr 08
2025
|
Jon Kessler |
SELL
Payment of exercise price or tax liability
|
Direct |
101,545
-24.79%
|
$8,022,055
$79.88 P/Share
|
Apr 08
2025
|
Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
52,078
-28.03%
|
$4,114,162
$79.88 P/Share
|
Apr 04
2025
|
Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,881
-13.55%
|
$692,718
$78.26 P/Share
|
Apr 03
2025
|
Stephen Neeleman FOUNDER AND VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct |
1,316
-1.06%
|
$109,228
$83.88 P/Share
|
Apr 03
2025
|
Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,839
-6.88%
|
$401,637
$83.87 P/Share
|
Apr 03
2025
|
Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,800
-2.0%
|
$315,400
$83.88 P/Share
|
Apr 03
2025
|
James M Lucania EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,212
-4.39%
|
$349,596
$83.88 P/Share
|
Apr 03
2025
|
Delano Ladd EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-1.43%
|
$112,216
$83.88 P/Share
|
Apr 02
2025
|
Stephen Neeleman FOUNDER AND VICE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
36,055
+13.59%
|
-
|
Apr 02
2025
|
Jon Kessler |
BUY
Grant, award, or other acquisition
|
Direct |
205,055
+33.36%
|
-
|
Apr 02
2025
|
Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,495
+18.04%
|
-
|
Apr 02
2025
|
Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
134,079
+28.56%
|
-
|
Apr 02
2025
|
James M Lucania EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,721
+17.04%
|
-
|
Apr 02
2025
|
Delano Ladd EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
31,662
+15.54%
|
-
|
Apr 02
2025
|
Scott Cutler President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,076
+26.93%
|
-
|
Apr 01
2025
|
Delano Ladd EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.62%
|
$34,365
$87.93 P/Share
|
Apr 01
2025
|
Stephen Neeleman FOUNDER AND VICE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-0.61%
|
$46,806
$87.93 P/Share
|